Medical Cannabis: Overview of Emerging Legal Issues and their Impact on the International Market. The international panel of experts will notably discuss the differences in regulations between medical cannabis and pharmaceutical cannabis, how IP is becoming an essential topic with pharmaceutical cannabis medicines, and how it could also impact medical cannabis in the short run.
This panel will discuss the most relevant issues within this area and the best practices applied by leading practitioners in this field. The panel will provide an overview of financing opportunities and methods, timing for investments and other financing vehicles, and positioning your clients for responsible growth.
Jeena Cho will cover resilience, work/life integration, and wellness in the workplace. Her area of expertise includes women’s issues, diversity, wellness, productivity, mindfulness, and meditation. Richard Carlton will be covering substance abuse and depression disorders. He will dive into the relation between practicing law and the mentality necessary to "succeed" at practicing law.
Learn about the hemp-derived Minnesota Model and how it is viewed as a preview to what will happen on the federal level. As goes Minnesota, so goes the rest of the nation? Join local and national speakers for their analysis and predictions, who will also discuss novel/intoxicating hemp-derived cannabinoids and their regulation under both state and federal law, including Delta-8 THC, THC-O, and others.
Our distinguished panel of judges will hear argument from both sides—petitioners and the government—and make a decision regarding the legality of marijuana’s continued classification as a Schedule I substance. Come see the exciting hearing unfold!
Navigating the Highs and Lows of Cannabis Regulatory Compliance—Insights, Best Practices, and Hurdles. Examine regulatory compliance “hot topics”, including maintaining state licenses and navigating enforcement actions, and explore best practices for corporate governance, novel partnership agreements such as IP licensing and white labeling, and regulatory considerations of various exit strategies for mature cannabis enterprises.
Join licensing experts from Dutchie and INCBA as they discuss New York’s newly available Adult-Use Cannabis license applications, including tips for success based on experience with prior application rounds and discussions with New York’s top cannabis regulators. This program is accredited for 1 hour of CLE.
Pathways to Ending Federal Prohibition: An Overview of Descheduling & Rescheduling. In 2022, President Biden directed his administration to conduct a review of the status of cannabis under the Controlled Substances Act. This session examines the review process for descheduling and rescheduling and their potential impacts.
This is the final installment of INCBA’s Business Law - Formation series. This panel will discuss the nuts and bolts of raising money including, securities laws, what is a security, registration requirements, exemptions to registration, types of investment vehicles, and investor disclosure documents.